Kenvue earnings top estimates in J&J spinoff’s first quarterly report since IPO

J&J still owns a 90% stake in Kenvue, meaning it can generally control the direction of the consumer health spinoff’s business for the time being.

Previous post Movers & Shakers: Netflix shares slump on revenue outlook, Tesla stock slips on margin fears and other stocks on the move
Next post American Airlines raises 2023 profit forecast after strong second quarter